Drug firm staff ‘stalled probe’
AUSTRALIAN staff of pharmaceutical giant Merck & Co sought to delay a federal government review into the safety and pricing of its blockbuster anti-arthritis drug Vioxx.
Our Team
Latest
Killer must pay ex-wife $225,000 compo
A MAN who killed his three children by driving them into a dam in 2005 has been ordered to pay the mother of his children $225,000.
Vioxx made heart warnings softer
SENIOR staff at pharmaceutical giant Merck & Co sought to make “more palatable” a recommended warning by the government drugs regulatory body against the long-term use of Vioxx by people with a history of heart conditions.
US expert to back firm on Vioxx
AN American heart expert is being flown to Australia to testify for pharmaceutical giant Merck & Co that its anti-arthritis drug Vioxx could actually protect some people from having a heart attack, rather than cause one.
Science unproven on Vioxx: drug firm
THE international pharmaceutical giant behind anti-arthritis drug Vioxx maintains there is not enough scientific proof to link the drug to heart attacks, despite the company withdrawing it from the market almost five years ago.
Take only as directed
A case unfolding in the Federal Court throws a spotlight on the practices used by drug manufacturers to market their products.
Doctors feted by Merck over Vioxx
SALES representatives from the international pharmaceutical giant that produced anti-arthritis drug Vioxx wined and dined scores of doctors at some of the country’s most expensive restaurants, including Melbourne’s Flowerdrum, Circa the Prince and Jacques Reymond.
Lure of lucre drove Vioxx marketeers
AN Australian sales team of the drug company that manufactured anti-inflammatory drug Vioxx boasted that “money!” was its main motivation, in a puffy profile piece in an internal company newsletter.
Evidence, spin collide in Vioxx case
THERE are two battles being waged in the case between Graeme Peterson and Merck & Co over whether Vioxx caused his heart attack.
Scientist ‘worried’ at Vioxx risk
A MERCK scientist involved in developing the drug Vioxx admitted the possibility of increased heart attacks was “of great concern”.
Original URL: https://www.theaustralian.com.au/author/milanda-rout/page/125